Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Armodafinil adjunctive therapy for bipolar I depression
2009-016634-27Phase 3Completed
- Sponsor
- Cephalon, Inc.
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of armodafinil in bipolar I disorder and major depressive episode (MDE) (3 arms), sponsored by Cephalon, Inc. Primary endpoint: Mean change from baseline in IDS-C30 total score. Started Mar 2010; status: completed.
02
Drugs
armodafinil
03
Conditions
bipolar I disordermajor depressive episode (MDE)
Beyond the preview
Go deeper on 2009-016634-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016634-27.